Moderna Cancer Vaccines Patent Grant

The USPTO has granted patent US12582609B2 to ModernaTX, Inc. for cancer ribonucleic acid (RNA) vaccines. The patent covers cancer RNA vaccines, methods of use, and compositions. This grant is a routine notification of intellectual property protection.

Patent: ROS-detonable Nanoclusters for Anti-Restenotic Therapy

The USPTO has granted a patent (US12582613B2) for biomimetic, reactive oxygen species-detonable nanoclusters designed for anti-restenotic therapy. The technology, assigned to the University of Virginia Patent Foundation, involves nanoclusters with self-assembled cores and biomimetic membrane coatings that can deliver anti-restenotic drugs.

USPTO Patent Granted for Dissociative Disorder Treatment Methods

The USPTO has granted a patent (US12582616B2) to The Board of Trustees of the Leland Stanford Junior University for methods of treating dissociative disorders. The patent covers agents that modulate neural activity in the posteromedial cortex to treat these conditions.

USPTO Grants Patent for Bis-biguanide Compounds in Cancer Management

The USPTO has granted a patent (US12582618B2) to Emory University for bis-biguanide compounds and pharmaceutical compositions for managing cancer, particularly lung cancer. The patent covers methods of treatment and related compositions, with an effective grant date of March 24, 2026.

Bifunctional compounds for degrading BTK via ubiquitin pathway

The USPTO has granted patent US12582722B2 to Nurix Therapeutics, Inc. for bifunctional compounds designed to degrade Bruton's tyrosine kinase (BTK) through the ubiquitin proteolytic pathway. The patent covers novel compounds and pharmaceutical compositions for treating various diseases.

USPTO Patent Grant: Theranostic Agents for PSMA Positive Cancers

The USPTO has granted a patent (US12582728B2) to Memorial Sloan Kettering Cancer Center for theranostic agents targeting PSMA positive cancers. The patent covers compositions and methods for detecting and treating cancer using novel radiohalogenated PSMA targeting agents for diagnostic imaging and radiation therapy.

USPTO Patent Grant: Kit for Producing and Storing Radiopharmaceuticals

The USPTO has granted patent US12582729B2 to Wake Forest University Health Sciences for a kit technology designed for the production and long-term storage of Zr-89-PET radiopharmaceuticals. The patent covers improved stability for radiopharmaceuticals and a method for their production.

Senate Bill Waives Notice for Posthumous Promotion of Captain Cody Khork

The U.S. Senate has passed S.4138, a bill to waive the 60-day notice requirement for the posthumous honorary promotion of Captain Cody Khork of the United States Army to the rank of major. This legislative action specifically addresses an individual case to facilitate the promotion.

GG v. Noem et al - Other Immigration Actions

A civil case titled GG v. Noem et al was filed on March 23, 2026, in the U.S. District Court for the Northern District of California. The case involves 'Other Immigration Actions' and seeks an injunction against the U.S. government or APA vacatur.

Patillero, Jr. v. RH, Inc. - Other Fraud

A new civil case, Patillero, Jr. v. RH, Inc., was filed on March 23, 2026, in the U.S. District Court for the Northern District of California. The case is based on diversity jurisdiction and involves a claim of 'Other Fraud'. RH, Inc. filed a Notice of Removal from Marin Superior Court.